10 reports

Forecasts by Containers (Non-Pressurised Containers, Pressurised Containers), by Device (Nasal Unidose, Nasal Bi Dose, Nasal Multi Dose), by Dosage Form (Nasal Spray, Nasal Drops and Liquids, Nasal Gels, Nasal Powders, Other), by End-user (Hospitals, Home Health Care, Ambulatory Surgery Center, Specialty Clinics, Vaccination Centres,...

  • Nasal Drug Delivery
  • World
  • APAC
  • Europe

Nasal Drug Delivery market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Nasal Drug Delivery Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Nasal Drug Delivery types, applications. Further, Nasal Drug...

  • Nasal Drug Delivery
  • World

Global Nasal Drug Delivery Market, By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others), By Dosage Form (Sprays, Drops, Powder, Gels & Ointments), By Container Type (Non-pressurized Containers, Pressurized Containers), By Basis of System (Metered Dose, Multi-Dose, Unit Dose), By Therapeutic...

  • Nasal Drug Delivery
  • World
  • Chronic Disease Prevalence

Nasal Drug Delivery Market Report Overview Nasal Drug Delivery market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Nasal Drug Delivery market types and applications. It is a focused study on Nasal Drug Delivery market space including global...

  • Nasal Drug Delivery
  • World
  • Health Provider Density

Abstract: - Global Nasal Drug Delivery Technology Market to Reach $73.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Nasal Drug Delivery Technology estimated at US$51.6 Billion in the year 2020, is projected to reach a revised size of US$73.3 Billion by 2027, growing at a CAGR of 5.1% over the...

  • Nasal Drug Delivery
  • World
  • China
  • United States

Nasal Drug Delivery Technology Market Forecast 2020-2030: Nasal Sprays: Non-Pressurised Containers & Pressurised Containers, Nasal Drops & Liquids, Nasal Gels, Nasal Powders; Multi Dose Nasal Devices, Bi-Dose Nasal Devices, Unit Dose Nasal Devices; Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma; Ambulatory Surgery Centres,...

  • Nasal Drug Delivery
  • World

Nasal Drug Delivery Technology Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Nasal Drug Delivery Technology Market size, Outlook and Opportunities 2019- 2025: By Containers (Non-Pressurized Containers and Pressurized Containers), By Systems (Multi Dose, Bi-Dose and Unit Dose), By Dosage Form (Nasal...

  • Nasal Drug Delivery
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Summary Bespak Europe Ltd (Bespak), a subsidiary of Consort Medical plc is a medical device company that provides inhalation systems.The company offers products such as inhalation devices, injectables, medical check valves and nasal products. Its inhalation devices comprise dose counting actuator, easfill metered...

  • Injectable Delivery
  • Pulmonary Delivery
  • Nasal Drug Delivery
  • Europe
  • Drug Approval
  • Medical Devices Sales

Nasal Drug Delivery Technology Market Analysis Report By Therapeutic Application (Asthma, Rhinitis), By Dosage Form (Powder, Gel, Spray, Drops), By Container Type, And Segment Forecasts, 2019 - 2025 The global nasal drug delivery systems market size is expected to reach USD 67.99 billion by 2025 expanding at 6.5% CAGR,...

  • Nasal Drug Delivery
  • Asthma
  • World
  • North America
  • APAC
  • Asthma Prevalence

The global nasal drug delivery technology market is projected to reach USD 64.20 billion by 2021 from USD 44.00 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing self-administration practices among the...

  • Nasal Drug Delivery
  • United States
  • Europe
  • North America
  • Asia
  • United Kingdom
  • World
  • Japan
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Drug Approval